计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| V303115-200mg |
200mg |
现货 ![]() |
| |
| V303115-1g |
1g |
现货 ![]() |
| |
| V303115-5g |
5g |
现货 ![]() |
|
| 别名 | 伐地那非 |
|---|---|
| 英文别名 | Levitra | Vivanza | Vardenafil hydrochloride |
| 规格或纯度 | Moligand™, ≥99% |
| 英文名称 | Vardenafil |
| 储存温度 | 避光,-20°C储存,充氩 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 作用机制 | 磷酸二酯酶 5A 抑制剂 |
| 产品介绍 |
Vardenafil (Vivanza) 是选择性、高效的、具有口服活性的磷酸二酯酶5抑制剂,IC50=0.7 nM。它能够非竞争性地抑制环磷酸鸟苷水解,从而提高 cGMP 水平。它对 PDE1 (180 nM),PDE6 (11 nM),PDE2,PDE3,PDE4 (<1000 nM) 具有选择性。它可用于研究勃起功能障碍。 Vardenafil (Vivanza) is an oral therapy for the treatment of erectile dysfunction. It is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). Penile erection is a hemodynamic process initiated by the relaxation of smooth muscle in the corpus cavernosum and its associated arterioles. During sexual stimulation, nitric oxide is released from nerve endings and endothelial cells in the corpus cavernosum. Nitric oxide activates the enzyme guanylate cyclase resulting in increased synthesis of cyclic guanosine monophosphate (cGMP) in the smooth muscle cells of the corpus cavernosum. The cGMP in turn triggers smooth muscle relaxation, allowing increased blood flow into the penis, resulting in erection. The tissue concentration of cGMP is regulated by both the rates of synthesis and degradation via phosphodiesterases (PDEs). The most abundant PDE in the human corpus cavernosum is the cGMPspecific phosphodiesterase type 5 (PDE5); therefore, the inhibition of PDE5 enhances erectile function by increasing the amount of cGMP. |
| 纯度 | ≥99% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 504773253 |
|---|---|
| 分子类型 | 小分子 |
| IIUPAC Name | 2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one |
| INCHI | 1S/C23H32N6O4S/c1-5-8-20-24-16(4)21-23(30)25-22(26-29(20)21)18-15-17(9-10-19(18)33-7-3)34(31,32)28-13-11-27(6-2)12-14-28/h9-10,15H,5-8,11-14H2,1-4H3,(H,25,26,30) |
| InChi Key | SECKRCOLJRRGGV-UHFFFAOYSA-N |
| Smiles | CCCC1=NC(=C2N1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C |
| Isomeric SMILES | CCCC1=NC(=C2N1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C |
| PubChem CID | 135400189 |
| 分子量 | 488.60 |
| 溶解性 | DMSO: 45 mg/mL (92.1 mM) |
|---|---|
| 敏感性 | 湿度和光敏感 |
| 分子量 | 488.600 g/mol |
| XLogP3 | 2.500 |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 8 |
| 可旋转键计数Rotatable Bond Count | 8 |
| 精确质量Exact Mass | 488.221 Da |
| 单同位素质量Monoisotopic Mass | 488.221 Da |
| 拓扑极表面积Topological Polar Surface Area | 118.000 Ų |
| 重原子数Heavy Atom Count | 34 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 854.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 预防措施声明 |
P264: 处理后要彻底洗手。 |
|---|
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | V303115 | |
| 分析证书 | V303115 | |
| 分析证书 | V303115 | |
| 分析证书 | V303115 | |
| 分析证书 | V303115 | |
| 分析证书 | V303115 | |
| 分析证书 | V303115 | |
| 分析证书 | V303115 | |
| 分析证书 | V303115 | |
| 分析证书 | V303115 | |
| 分析证书 | V303115 |
¥579.12
¥205.90
¥112.90
| 1. Cheng Yang, Pei-Zhi Dong, Zhou-Ning Jiang, Yanan Li, Yue-Hong Pang. (2025) Amino-functionalized Fe₃O₄-based covalent organic framework for efficient magnetic solid-phase extraction of three illegally added phosphodiesterase-5 inhibitors in functional food. Food Bioscience, 65 (106070). [10.1016/j.fbio.2025.106070] |